MDWD
Price
$14.37
Change
+$0.06 (+0.42%)
Updated
Jun 10, 01:30 PM (EDT)
Capitalization
183.79M
70 days until earnings call
Intraday BUY SELL Signals
TARA
Price
$3.87
Change
-$0.10 (-2.52%)
Updated
Jun 10, 02:19 PM (EDT)
Capitalization
222.85M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MDWD vs TARA

Header iconMDWD vs TARA Comparison
Open Charts MDWD vs TARABanner chart's image
MDWD vs TARA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MDWD vs. TARA commentary
Jun 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDWD is a Hold and TARA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 10, 2026
Stock price -- (MDWD: $14.30 vs. TARA: $3.96)
Brand notoriety: MDWD and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDWD: 98% vs. TARA: 144%
Market capitalization -- MDWD: $183.79M vs. TARA: $222.85M
MDWD [@Biotechnology] is valued at $183.79M. TARA’s [@Biotechnology] market capitalization is $222.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDWD’s FA Score shows that 1 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • MDWD’s FA Score: 1 green, 4 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, TARA is a better buy in the long-term than MDWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDWD’s TA Score shows that 4 TA indicator(s) are bullish while TARA’s TA Score has 4 bullish TA indicator(s).

  • MDWD’s TA Score: 4 bullish, 5 bearish.
  • TARA’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, MDWD is a better buy in the short-term than TARA.

Price Growth

MDWD (@Biotechnology) experienced а +3.92% price change this week, while TARA (@Biotechnology) price change was -8.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -6.95%, and the average quarterly price growth was -3.44%.

Reported Earning Dates

MDWD is expected to report earnings on Aug 19, 2026.

TARA is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARA($223M) has a higher market cap than MDWD($184M). MDWD YTD gains are higher at: -22.535 vs. TARA (-25.610). MDWD has higher annual earnings (EBITDA): -24.21M vs. TARA (-69.69M). TARA has more cash in the bank: 136M vs. MDWD (44.6M). TARA has less debt than MDWD: TARA (3.06M) vs MDWD (8.13M). MDWD has higher revenues than TARA: MDWD (14.5M) vs TARA (0).
MDWDTARAMDWD / TARA
Capitalization184M223M83%
EBITDA-24.21M-69.69M35%
Gain YTD-22.535-25.61088%
P/E RatioN/AN/A-
Revenue14.5M0-
Total Cash44.6M136M33%
Total Debt8.13M3.06M266%
FUNDAMENTALS RATINGS
MDWD vs TARA: Fundamental Ratings
MDWD
TARA
OUTLOOK RATING
1..100
5754
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8065
P/E GROWTH RATING
1..100
5100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARA's Valuation (14) in the null industry is somewhat better than the same rating for MDWD (72) in the Pharmaceuticals Other industry. This means that TARA’s stock grew somewhat faster than MDWD’s over the last 12 months.

TARA's Profit vs Risk Rating (100) in the null industry is in the same range as MDWD (100) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to MDWD’s over the last 12 months.

TARA's SMR Rating (100) in the null industry is in the same range as MDWD (100) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to MDWD’s over the last 12 months.

TARA's Price Growth Rating (65) in the null industry is in the same range as MDWD (80) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's P/E Growth Rating (5) in the Pharmaceuticals Other industry is significantly better than the same rating for TARA (100) in the null industry. This means that MDWD’s stock grew significantly faster than TARA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDWDTARA
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 21 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
MDWD
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRTPX22.99N/A
N/A
Vanguard Real Estate II Index
FSCCX37.49N/A
N/A
Nuveen Small Cap Value I
FSCDX35.22N/A
N/A
Fidelity Advisor Small Cap A
ADEIX17.56N/A
N/A
Ancora Dividend Value Equity I
DDERX16.80N/A
N/A
Nomura Wealth Builder R6

MDWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDWD has been loosely correlated with ABUS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MDWD jumps, then ABUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDWD
1D Price
Change %
MDWD100%
+0.63%
ABUS - MDWD
39%
Loosely correlated
+0.24%
AUTL - MDWD
37%
Loosely correlated
+0.34%
TARA - MDWD
33%
Loosely correlated
-1.86%
TRVI - MDWD
32%
Poorly correlated
+0.67%
NAMS - MDWD
30%
Poorly correlated
-1.84%
More

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with AMLX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
-1.86%
AMLX - TARA
40%
Loosely correlated
+4.23%
ARVN - TARA
37%
Loosely correlated
+0.77%
PCVX - TARA
36%
Loosely correlated
+1.15%
BCAX - TARA
36%
Loosely correlated
+2.24%
IMTX - TARA
36%
Loosely correlated
-0.65%
More